A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease (Latitude CD)

Study description

The LATITUDE CD Study is evaluating the efficacy and safety of an investigational oral treatment for those who were diagnosed with Crohn’s disease (CD) and are currently experiencing symptoms. Participants will attend up to 14 scheduled study visits (and any additional study visits if needed) over the course of about a year.

Patient Participation Requirements 

• Give correct information about your health history and condition
• Tell the study doctor/staff about any health problems you have during this study
• Tell the study doctor/staff about any new treatments you take during this study or any changes to your current treatments
• Do not take part in any other medical research studies
• Do not take any other treatments or remedies unless the study doctor/staff has approved them beforehand, including prescription and over-the-counter drugs such as vitamins and herbs

Possible risks and side effects

The use of the study drug is investigational (experimental) for the purposes of this study.  The clinical trial investigator will review with you all the known risks and side effects to help you determine if you would like to participate in the trial.